Follow us on:

Linkedin Facebook

Johnson Matthey completes sale of its Diagnostic Services business

Johnson Matthey
[shareaholic app="share_buttons" id_name="post_below_content"]

Johnson Matthey Plc (LON:JMAT), has announced that, further to the announcement on 3rd May 2023, it has completed the sale of its Diagnostic Services business on 29th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers’ products. 

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Pharma

    Johnson Matthey Plc hosting PGM Services seminar for investors and analysts today

    Join Johnson Matthey plc (LON:JMAT) as they host a PGM Services seminar, revealing how PGM Services drive the net zero transition and unlock growth opportunities.
    Broker Ratings

    Johnson Matthey PLC 16.0% potential upside indicated by Berenberg Bank

    Broker Ratings

    Johnson Matthey PLC 30.6% potential upside indicated by Deutsche

    Broker Ratings

    Johnson Matthey PLC 28.2% potential upside indicated by Deutsche

    Broker Ratings

    Johnson Matthey PLC .6% potential upside indicated by Berenberg Bank

    Broker Ratings

    Johnson Matthey PLC 16.7% potential upside indicated by Jefferies

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.